国际肿瘤学杂志

国际肿瘤学杂志 ›› 2017, Vol. 44 ›› Issue (1): 60-62.doi: 10.3760/cma.j.issn.1673-422X.2017.01.016

• 综述 • 上一篇    下一篇

非小细胞肺癌孤立性骨转移的治疗

董熠,魏月华,胡伟国,宋启斌   

  1. 430060 武汉大学人民医院肿瘤中心
  • 出版日期:2017-01-08 发布日期:2016-12-07
  • 通讯作者: 宋启斌，Email: qibinsong@163.com E-mail:qibinsong@163.com
  • 基金资助:

    国家自然科学基金（81372407）

Therapy for non-small cell lung cancer patients with solitary bone metastases

Dong Yi, Wei Yuehua, Hu Weiguo, Song Qibin   

  1. Cancer Center, Renmin Hospital of Wuhan University, Wuhan 430060, China
  • Online:2017-01-08 Published:2016-12-07
  • Contact: Song Qibin, Email: qibinsong@163.com E-mail:qibinsong@163.com
  • Supported by:

    National Natural Science Foundation of China (81372407)

PDF

1279

被引次数

3

摘要： 非小细胞肺癌（NSCLC）骨转移的治疗方法有手术、化疗、放疗等。近年来分子靶向治疗如地诺单抗成为NSCLC骨转移新的治疗方法。尽管治疗手段众多，但是NSCLC骨转移患者预后仍未得到明显改善。对于孤立性骨转移患者，积极的治疗可改善患者的生存及预后。

关键词: 骨肿瘤, 癌, 非小细胞肺, 放射疗法, 抗肿瘤药； 外科手术

Abstract: The therapeutic approaches for non-small cell lung cancer （NSCLC） patients with solitary bone metastases include surgery, radiotherapy, chemotherapy and so on. Recently, molecular targeted therapy such as the Denosumab has become a new option. Though there are so many options, the outcomes of the NSCLC with bone metastases are not so good. But for those with solitary bone metastases, radical treatment is necessary to improve the survival time and prognosis.

Key words: Bone neoplasms, Carcinoma, non-small-cell lung, Radiotherapy, Antineoplastic agents, Surgical procedures, operative